PhD-led consulting for early-stage biotech and CRO teams

Translating complex science into confident decisions

PhD-led consulting in medicinal chemistry and ADME strategy to reduce risk, accelerate timelines, and improve program success.

Book a 30-minute Strategy Call Explore Services

What we do

We work with early-stage biotech and CRO teams to identify lead, optimize hit-to-lead (H2L), identify risks early, optimize drug discovery strategies, and accelerate decision-making across medicinal chemistry, ADME, and translational science.

Why SARsyntax

We do not just analyze data. We help you decide what to do next.

About

Scientific leadership grounded in real-world discovery and CRO execution

Farhana Islam, PhD

Co-Founder — organic and medicinal chemist with CRO and pharma experience at Curia and GSK.

Tasdique Quadery, PhD

Co-Founder — process chemist with CRO experience at Curia.

Why teams choose SARsyntax

SARsyntax helps clients identify risk sooner, optimize discovery strategy earlier, and make clearer decisions across medicinal chemistry, ADME, and translational science.

PhD in Organic Chemistry

10+ years in drug discovery and development

Experience across medicinal chemistry, ADME/PK, and translational science

Proven ability to connect science with decision-making

Service

Three ways we support early-stage candidate selection

Flexible support for teams that need sharper program strategy, cross-functional decision support, or stronger external proposals.

Strategy Call

30-minute deep-dive into your program

Identify key risks and bottlenecks

Actionable recommendations you can implement immediately

Project Advisory

Weekly or biweekly scientific guidance

Cross-functional alignment across chemistry, biology, and ADME

Decision support to keep programs moving

Proposal / RFP Support

Scientific strategy and positioning

Improve clarity, competitiveness, and win rate

Support stronger external communication with clients and stakeholders

Selected Outcome

Commercial traction and scientific delivery backed by measurable outcomes

Client-Based Outcomes

Recognized as Most Valuable Player (2024) at Curia Global Inc for leading initiatives that improved client and stakeholder engagement across international teams (U.S., U.K., India).

Secured 10+ clients and generated $1.5M in revenue, designed proposal pricing and scope frameworks, improving margins by 10–20%.

Delivered 50+ integrated client-ready deliverables spanning structure-based design, synthetic chemistry, ADMET, toxicology, and CMC.

Independently managed the full BD lifecycle (RFP response, scope design, pricing, and delivery) across CRO and biotech clients.

Drove research program by drafting persuasive research proposals and reports that articulated translational impact, securing $1M+ in NIH R01 funding and enabling 10 new collaborations.

Scientific Outcomes

Designed structure- and ligand-based discovery workflows integrating CADD, retrosynthesis, and SAR modeling, accelerating hit-to-lead optimization across client projects. (>20 projects)

Identified 250+ potential inhibitors with CADD, enhancing potency and selectivity.

Achieved 50% improvement in compound half-life while reducing hERG inhibition and CYP450 binding, leading to metabolically stable candidates.

Leveraged AI to enhance scientific productivity, leading 10+ discovery projects that used AI-driven virtual screening to analyze over 1 million compounds and accelerate decision-making for chemistry teams.

Contributed to multiple inflammation and oncology programs and enabled 10 preclinical candidate nominations.

Managed the full-cycle product vision for 4 small molecule R&D programs, from early discovery (hit-gen) through development (lead-op), driving 4 molecules to clinical-candidate nomination.

How it works

A simple process built for fast decisions

Book a strategy call

Share your challenge or program

Get clear, actionable next steps

Book a call

Need clarity on your drug discovery program?

Book your strategy session now and get practical scientific direction you can use right away.

30-minute Strategy Call

Calendly: farhanap40/30min

Book a 30-minute Strategy Call